Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Clin Chim Acta. 2018 Jul;482:120-123. doi: 10.1016/j.cca.2018.04.007. Epub 2018 Apr 5.
Although remnant-like particle cholesterol (RLP-C) has been associated with coronary artery disease (CAD) in the general population, few data exist regarding this issue in patients with familial hypercholesterolemia (FH). The aim of our study was to investigate the association between RLP-C and the presence of CAD in patients with FH.
We examined 282 patients with FH (144 males, mean age, 41 ± 17 years) whose RLP-C levels were measured. We assessed the baseline characteristics, including lipid levels, other conventional risk factors for cardiovascular events, the presence of CAD, and the serum RLP-C levels.
Serum RLP-C levels significantly correlated with serum triglyceride (TG) levels (Pearson's r = 0.631, p < 0.001). We observed that a larger proportion of individuals in the higher tertiles of serum RLP-C had a larger number of diseased coronary arteries (p < 0.001 for the trend of multi-vessel disease). Logistic regression analysis, after adjusting for age, sex, hypertension, diabetes, smoking, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and lipoprotein (a) [Lp(a)], revealed that RLP-C was significantly associated with CAD [odds ratio (OR): 1.08, 95% confidence interval (CI): 1.00-1.16, p = 0.046]; however, adding serum TG levels into the logistic regression model nullified this association (OR: 1.07, 95% CI: 0.98-1.17, p = 0.141), whereas Lp(a) was independently associated with CAD (OR: 1.02, 95% CI: 1.00-1.03, p = 0.015).
Serum RLP-C levels were significantly associated with the presence and severity of CAD in patients with FH. However, the clinical usefulness of measuring RLP-C levels beyond that of measuring TG levels should be further assessed.
尽管残粒样颗粒胆固醇(RLP-C)与普通人群的冠状动脉疾病(CAD)相关,但在家族性高胆固醇血症(FH)患者中,关于这一问题的数据很少。我们的研究目的是探讨 FH 患者 RLP-C 与 CAD 之间的关系。
我们检查了 282 名 FH 患者(144 名男性,平均年龄 41±17 岁)的 RLP-C 水平。我们评估了基线特征,包括血脂水平、心血管事件的其他传统危险因素、CAD 的存在以及血清 RLP-C 水平。
血清 RLP-C 水平与血清甘油三酯(TG)水平显著相关(Pearson r=0.631,p<0.001)。我们发现,血清 RLP-C 水平较高的个体中,患有更多病变冠状动脉的比例更大(多支病变趋势的 p<0.001)。在调整年龄、性别、高血压、糖尿病、吸烟、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和脂蛋白(a)[Lp(a)]后,Logistic 回归分析显示,RLP-C 与 CAD 显著相关[比值比(OR):1.08,95%置信区间(CI):1.00-1.16,p=0.046];然而,将血清 TG 水平加入 Logistic 回归模型中消除了这种关联(OR:1.07,95%CI:0.98-1.17,p=0.141),而 Lp(a)与 CAD 独立相关(OR:1.02,95%CI:1.00-1.03,p=0.015)。
血清 RLP-C 水平与 FH 患者 CAD 的存在和严重程度显著相关。然而,测量 RLP-C 水平的临床实用性应进一步评估。